Twin Cities Business — Francis Medical has just received a fresh infusion of cash on its journey to treat prostate cancer.

This week, the Maple Grove-based company announced that it has closed on an $80 million Series C funding round, bringing its total raised to date to $160 million. Francis Medical is developing technology that uses water vapor to treat prostate cancer. One day, that could expand to the treatment of cancers in the bladder and kidney, said Mike Kujak, the company’s president and CEO.

For now, the startup is in the midst of a clinical study examining the effectiveness of its technology in treating prostate cancer in 235 men. In a Friday interview, Kujak said the company expects to release initial data from that study sometime in February, with plans to file for 510(k) clearance from the U.S. Food and Drug Administration in July. If all goes to plan, the company could get FDA approval as soon as October and make the technology commercially available across the country.

Read more on Twin Cities Business